Rhythm Pharmaceuticals Inc (RYTM)
38.27
-1.44
(-3.63%)
USD |
NASDAQ |
Apr 25, 13:35
Rhythm Pharmaceuticals Free Cash Flow (Quarterly): -29.38M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -29.38M |
| September 30, 2023 | -29.25M |
| June 30, 2023 | -41.09M |
| March 31, 2023 | -36.48M |
| December 31, 2022 | -34.00M |
| September 30, 2022 | -47.08M |
| June 30, 2022 | -42.87M |
| March 31, 2022 | -53.76M |
| December 31, 2021 | -40.54M |
| September 30, 2021 | -40.27M |
| June 30, 2021 | -37.09M |
| March 31, 2021 | -33.54M |
| December 31, 2020 | -29.21M |
| September 30, 2020 | -27.16M |
| Date | Value |
|---|---|
| June 30, 2020 | -29.73M |
| March 31, 2020 | -36.10M |
| December 31, 2019 | -32.22M |
| September 30, 2019 | -33.86M |
| June 30, 2019 | -27.86M |
| March 31, 2019 | -32.19M |
| December 31, 2018 | -21.38M |
| September 30, 2018 | -17.26M |
| June 30, 2018 | -12.49M |
| March 31, 2018 | -11.65M |
| December 31, 2017 | -7.94M |
| September 30, 2017 | -8.495M |
| June 30, 2017 | -6.142M |
| March 31, 2017 | -7.016M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-53.76M
Minimum
Mar 2022
-27.16M
Maximum
Sep 2020
-35.87M
Average
-34.00M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Pfizer Inc | 4.196B |
| Insmed Inc | -132.97M |
| Altimmune Inc | -16.53M |
| Regeneron Pharmaceuticals Inc | 776.20M |
| Viking Therapeutics Inc | -17.64M |